Backman v. Takeda Pharmaceutical Company Limited
| Peggye Backman |
| Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals America, Inc. and Eli Lilly and Company |
| 7:2011cv00212 |
| October 4, 2011 |
| US District Court for the Eastern District of North Carolina |
| Southern Division Office |
| SAMPSON |
| Louise Wood Flanagan |
| Personal Injury- Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
19
ORDER granting 18 Motion to Stay - All discovery, including this Court's December 19, 2011 Initial Order Regarding Planning and Scheduling, is hereby stayed in the United States District Court for the Eastern District of North Carolina, so that discovery may proceed in this action in the Actos MDL, subject to further proceedings not inconsistent with the Actos MDL upon any remand from the MDL. Signed by District Judge Louise Wood Flanagan on 12/27/2011. (Baker, C.)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
